Google launches AI Center in Berlin to connect science, industry, policy, and society
Google has opened a new AI Center in Berlin to accelerate collaboration across research, business, government, and civil society. The goal: strengthen AI research and application in Germany while expanding international cooperation.
At the opening, leaders from politics, science, and business underlined the strategic role of AI for Germany and Berlin as an innovation hub. Philipp Justus, Head of Google Germany, presented the Center and shared Google's commitment to AI innovation in the country. Federal Research Minister Dorothee Bär, Federal Digital Minister Karsten Wildberger, and Berlin's Governing Mayor Kai Wegner emphasized the Center's importance for translating research into impact.
Scientific focus at launch
Fabian Theis, Head of the Computational Health Center at Helmholtz Munich and Professor at TUM, brought a research-first perspective. He highlighted joint work between Google and the scientific community, including AI models for medical research that could simulate disease progression and support more accurate cancer diagnostics.
Two funded AI research projects in healthcare
Google.org is supporting several efforts that advance new AI methods and their safe use in medicine, including work within the relAI initiative for reliable AI led by scientists at Helmholtz Munich and TUM.
NextGen Health GenAI Benchmarks: Fabian Theis and Prof. Daniel Rückert (TUM) are co-developing strict evaluation standards for generative AI in healthcare. These benchmarks aim to ensure systems perform reliably and can be used safely in clinical settings.
Single Cell Foundation Models (Helmholtz Munich): Researchers are applying AI to characterize the diversity of individual cells. The target is clearer insight into disease mechanisms, opening paths to earlier diagnosis and more precise therapies.
Why this matters for researchers
- Closer links between labs, clinics, and industry can speed up validation and translation for AI-driven diagnostics and decision support.
- Shared benchmarks help separate promising models from risky ones-useful for grant design, regulatory dialogue, and clinical trials.
- Single-cell modeling at scale could improve target discovery, patient stratification, and longitudinal disease modeling.
- Policy engagement at the Center may support clearer guidance on evaluation, privacy, and safe deployment in healthcare.
What to watch next
- Publication and adoption of generative AI benchmarks across hospitals, biobanks, and research institutes.
- Evidence of clinical utility: prospective studies, external validation, and performance on real-world cohorts.
- Standards for data governance and model monitoring that make cross-institution collaboration simpler and safer.
For deeper context on cross-industry AI research efforts, explore AI for Science & Research. If your work intersects with clinical translation, see AI for Healthcare for methods, benchmarks, and use cases.
Source: Helmholtz Munich. Related institution: Technical University of Munich (TUM).
Your membership also unlocks:
